Nanolive will be present at the ASCB|EMBO meeting this year in Washington D.C., from the 3rd to the 7th of December, where we’ll be showcasing our vast range of label-free high content phenotypic solutions, that combine screening, imaging, and analysis to radically advance the study of living cells and provide novel biological insights.
If you are attending the meeting, don’t miss the opportunity to visit our team at booth #2225, to book your demo or to get more information on the latest tools to accelerate your drug discovery and to help you getting higher significance, earlier and faster!
Tech Talk
Join us for a tech talk “Nanolive: A Label-free High Content Phenotypic Solution for De-risking Drug Discovery and Development for Immuno-oncology, Cell Metabolism and Cytotoxicity Studies” on December 5th from 3.15 to 4.00pm, in Theater 1, presented by our US General Manager Jonathan Day and Scientific Communication Specialist Hope Amos.
Read our latest news
Online demo: Rethink high content screening workflows for smarter decisions
Unlocking mitochondrial stress as a drug discovery readout
